A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment
Clinical trial NCT04178460 · TERMINATED
Trial details
- NCT number
- NCT04178460
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2022-03-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.